link: http://ift.tt/1jaUDvL
Hot And Trending...
Trending
- The Theory of Free Banking
- SRSrocco put together a graph tracking production for the top-four gold producers. You will note a pretty consistent downward trend. If these forecasts hold, we are looking at a 23% drop in output over less than a decade. http://bit.ly/2I5FJVb http://bit.ly/2D3w91e
- Ron Paul Calls Out Ted Cruz
- The Indian government can't keep up with the mismatch in the demand and supply of new currency notes. http://bit.ly/2ol5xCb
- @juniorra22 It will turn into a bear market quickly if the Fed does not save it.
- Investing from an Austrian perspective.
- The latest issue of Silver News features some fascinating technological developments related to silver. http://bit.ly/2xRqo4O
- We have a return of the twin deficits here in 2018 – I’m talking about the budget deficit and the trade deficit. The last time that was a problem was in 1987. Result. We got a stock market crash. http://bit.ly/2ENWuW8
- On Cochrane's dream of equity-financing banking
- New Tool: Gold and Silver Bartering Made Easy @SchiffGold http://t.co/vhkAnY5cHH
Wednesday, September 23, 2015
CEO who raised price of drug by 5000%
I know everyone is hating on this guy, but here is my view on the whole thing. So yeah this guy may be a prick, but from purely an economic sense, what he did might not be so terrible. The patent that Turing Pharmaceuticals purchased is for Daraprim, and from what I know, the patent is actually expired, all he bought was the right to sell the branded drug. No one is producing it generically - yet. With the massive price hike surely some pharmaceutical companies will come in with generic versions of Daraprim and undercut Turing's prices and increase supply until there is competitive equilibrium. What do you think?